Is BioCorRx Inc. (BICX) a Buy, Sell, or Hold?
OTC : BICX
BioCorRx Inc.
$0.25 USD
$0 (0.0%)
- Volume
- 9.17K
- Average Volume
- 2.81K
- Market Capitalization
- $5.22M
- P/E Ratio
- -1.50
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.28
- Year Low
- $0.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.12
Company Overview
OTC
Lourdes Felix
Medical - Care Facilities
Healthcare
BICX
3
US
USD
Liquidity Metrics
-0.18
0.12
0.10
0.02
0.00
Sales & Valuation
$797.24K
5.95
-0.56
-2.56
-0.08
Profitability
-$0.19
-$3.44M
-391.15%
-401.07%
28.12%
-147.53%
P/E Metrics
-1.50
-0.02
-0.02
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-60.20
4/9
-$7.51M
$2.32M
$13.95M
-$3.02M
Key Metrics (TTM)
$7.12M
8.12
-2.41
0.12
28.12%
111.47%
-53.59%
-39.12%
-6718 days
Company Executives
| Name | Title |
|---|---|
| George N. Fallieras | Medical Consultant |
| Louis Charles Lucido | President & Chairman |
| Lourdes Felix | Chief Executive Officer, Chief Financial Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About BioCorRx Inc. (OTC:BICX) Stock
BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its core offerings is the BioCorRx recovery program, an innovative, non-addictive treatment model. This program uniquely combines proprietary naltrexone implants with extensive counseling services to support patient recovery. Additionally, the company provides the UnCraveRx weight management program, a medically supported initiative designed to curb food cravings. This program integrates pharmacological assistance with readily available virtual support focusing on lifestyle adjustments, fitness, and nutritional guidance. Looking to the future, BioCorRx is activel ... y advancing its product pipeline. This includes BICX101, an injectable naltrexone product, and BICX104, an implantable naltrexone device, both currently under development for the specific treatment of opioid addiction and alcoholism. The company's programs are made available to patients through a network of healthcare providers, independent licensed clinics, and other qualified healthcare professionals. Originally established as Fresh Start Private Management, Inc., the organization officially rebranded as BioCorRx Inc. in January 2014. Its corporate headquarters are situated in Anaheim, California.
Frequently Asked Questions
-
What is the current BioCorRx Inc. (BICX) stock price?
-
BioCorRx Inc.(OTC:BICX) stock price is $0.25 in the last trading session. During the trading session, BICX stock reached the peak price of $1.28 while $0.2 was the lowest point it dropped to. The percentage change in BICX stock occurred in the recent session was 0.0% while the dollar amount for the price change in BICX stock was $0.
-
BICX's industry and sector of operation?
-
The OTC listed BICX is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
-
Who are the executives of BICX?
-
George N. Fallieras | Medical Consultant
Louis Charles Lucido | President & Chairman
Lourdes Felix | Chief Executive Officer, Chief Financial Officer & Director
|
| -
How many employees does BICX have?
-
Number of BICX employees currently stands at 3. BICX operates from 2390 East Orangewood Avenue, Anaheim, CA 92806, US.
-
Link for BICX official website?
-
Official Website of BICX is: https://www.biocorrx.com
-
How do I contact BICX?
-
BICX could be contacted at phone #714 462 4880 and can also be accessed through its website. BICX operates from 2390 East Orangewood Avenue, Anaheim, CA 92806, US.
-
How many shares of BICX are traded daily?
-
The average number of BICX shares traded daily for last 3 months was 2.81K.
-
What is the market cap of BICX currently?
-
The market value of BICX currently stands at $5.22M with its latest stock price at $0.25